首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Prognostic gene-expression signature of carcinoma- associated fibroblasts in non-small cell lung cancer
【24h】

Prognostic gene-expression signature of carcinoma- associated fibroblasts in non-small cell lung cancer

机译:癌相关成纤维细胞在非小细胞肺癌中的预后基因表达特征

获取原文
获取原文并翻译 | 示例
       

摘要

The tumor microenvironment strongly influences cancer development, progression, and metastasis. The role of carcinoma-associated fibroblasts (CAFs) in these processes and their clinical impact has not been studied systematically in non-small cell lung carcinoma (NSCLC). We established primary cultures of CAFs and matched normal fibroblasts (NFs) from 15 resected NSCLC. We demonstrate that CAFs have greater ability than NFs to enhance the tumorigenicity of lung cancer cell lines. Microarray gene-expression analysis of the 15 matched CAF and NF cell lines identified 46 differentially expressed genes, encoding for proteins that are significantly enriched for extracellular proteins regulated by the TGF-β signaling pathway. We have identified a subset of 11 genes (13 probe sets) that formed a prognostic gene-expression signature, which was validated in multiple independent NSCLC microarray datasets. Functional annotation using protein-protein interaction analyses of these and published cancer stroma-associated gene-expression changes revealed prominent involvement of the focal adhesion and MAPK signaling pathways. Fourteen (30%) of the 46 genes also were differentially expressed in laser-capture-microdissected corresponding primary tumor stroma compared with the matched normal lung. Six of these 14 genes could be induced by TGF-β1 in NF. The results establish the prognostic impact of CAF-associated gene-expression changes in NSCLC patients.
机译:肿瘤微环境强烈影响癌症的发展,进展和转移。在非小细胞肺癌(NSCLC)中,尚未系统研究癌相关成纤维细胞(CAF)在这些过程中的作用及其临床影响。我们建立了CAF的原代培养,并从15个切除的NSCLC中匹配了正常成纤维细胞(NFs)。我们证明,CAF比NF具有更大的能力来增强肺癌细胞系的致瘤性。对15个匹配的CAF和NF细胞系的微阵列基因表达分析确定了46个差异表达的基因,编码的蛋白质显着富集了受TGF-β信号通路调节的细胞外蛋白质。我们已经鉴定出11个基因的子集(13个探针集),这些子集形成了预后基因表达特征,并在多个独立的NSCLC微阵列数据集中得到了验证。使用这些和已发表的癌症基质相关基因表达变化进行蛋白-蛋白相互作用分析的功能注释显示,粘着斑粘附和MAPK信号通路显着参与。与匹配的正常肺相比,在激光捕获显微切割的相应原发性肿瘤基质中,46个基因中的十四个(30%)也差异表达。 NF中的TGF-β1可以诱导这14个基因中的六个。结果确定了CACL相关基因表达变化对NSCLC患者的预后影响。

著录项

  • 来源
  • 作者单位

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9,Department of Biomedicine, Jonas Lies vei, N-5009 Bergen, Norway;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9,Departments of Medicine, University of Toronto, Toronto, ON, Canada M5A 2N4;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9,Departments of Com'puter Science, University of Toronto, Toronto, ON, Canada M5A 2N4,Departments of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5A 2N4;

    The Campbell Family Institute for Cancer Research, Ontario Cancer Institute at Princess Margaret Hospital, University Health Network, Toronto, ON, Canada M5G 2M9,Departments of Medical Biophysics, University of Toronto, Toronto, ON, Canada M5A 2N4,Departments of Laboratory of Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada M5A 2N4;

  • 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    integrin α11; NAViGaTOR; adenocarcinoma; extracellular matrix;

    机译:整合素α11;航海家;腺癌细胞外基质;
  • 入库时间 2022-08-18 00:40:46

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号